Sarah J. Cross — Endo Lab

article 2022

Impact of endometriosis on women’s life decisions and goal attainment: a cross-sectional survey of members of an online patient community

BMJ open ·doi:10.1136/bmjopen-2021-052765

OBJECTIVES: To examine women's perceptions of endometriosis-associated disease burden and its impact on life decisions and goal attainment. DESIGN: An anonymous online survey was distributed in October 2018 through the social media network …

article 2021

Development of a visual, patient-reported tool for assessing the multi-dimensional burden of endometriosis

Current medical research and opinion ·doi:10.1080/03007995.2021.1929896

OBJECTIVE: Inadequate communication about endometriosis symptom burden between women and healthcare providers is a barrier for optimal treatment. This study describes the development of the EndoWheel, a patient-reported assessment tool that…

article 2021

Real-World Effectiveness of Elagolix in Reducing Endometriosis Pain: 6-Month Results from Elagolix Longitudinal Outcomes (LOTUS) Study

·doi:10.1016/j.jmig.2021.09.431

article 2021

Treating Women with Endometriosis-Associated Pain during the COVID-19 Pandemic

·doi:10.1016/j.jmig.2021.09.435

article 2020

Effect of Elagolix in Women with Moderate to Severe Pelvic Tenderness or Induration: Results from Elaris EM-l and EM-II Clinical Trials

·doi:10.1016/j.jmig.2020.08.371

article 2020

PDB58 REAL WORLD EVIDENCE ON THE IMPACT OF ELAGOLIX UTILIZATION ON PAIN SYMPTOMS, TREATMENT PATTERNS AND HEALTH RESOURCE USE AMONG ENDOMETRIOSIS PATIENTS IN THE UNITED STATES

·doi:10.1016/j.jval.2020.04.245